NMPA Approval

Trimetazidine Dihydrochloride Sustained-release Tablets

Approval Number

国药准字H20203452

Company北大医药股份有限公司

Registration Date

September 2, 2020

Drug Information

Generic Name

盐酸曲美他嗪缓释片

Dosage Form

片剂

Strength

35mg

Drug Type

化学药品

Registration Date

September 2, 2020

Company Information

Applicant Company

Company Name北大医药股份有限公司

Company Address

重庆市北碚区水土镇方正大道21号

Manufacturing Company

Company Name

北京百美特生物制药有限公司;北大医药股份有限公司

Company Address

北京市平谷区中关村科技园区平谷园兴谷A区M2-9号；重庆市北碚区水土镇方正大道21号附2号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.